District Court issues ruling finding Adderall XR® patents infringed
Shire announces that its subsidiary, Shire Development, welcomes the favorable ruling against Abhai in connection with their ANDA for a generic version of Shire’s ADDERALL XR. ADDERALL XR is indicated for treatment of attention deficit hyperactivity disorder in children and adults. March 23, 2018